Aki Vartiainen
About Aki Vartiainen
Aki Vartiainen is a Global Trial Manager at Bristol Myers Squibb, specializing in early phase clinical trials in oncology, based in Boudry, Neuchâtel, Switzerland.
Company
Aki Vartiainen currently works at Bristol Myers Squibb, a global biopharmaceutical company. He operates from Boudry, Neuchâtel, Switzerland, serving as a Global Trial Manager. His role involves managing and overseeing clinical trials, collaborating with diverse country organizations around the world, and leading multifunctional and multinational specialist groups.
Title
Aki Vartiainen holds the position of Global Trial Manager at Bristol Myers Squibb. In this capacity, he is responsible for the management and coordination of clinical trials on a global scale. His expertise encompasses early phase clinical trials with a special focus on the field of oncology.
Education and Expertise
Aki Vartiainen completed his Master of Science (M.Sc.) in Biochemistry at the University of Turku, studying from 2004 to 2013. He also pursued a doctoral degree in Diabetes biology/molecular biology at the University of Helsinki, although he did not complete this PhD. Additionally, he received Project Management F.E.C training from Aalto University Executive Education Ltd. His specialized knowledge includes early-phase clinical trials, oncology, and research on autoimmune and neurodegenerative diseases.
Background
Aki Vartiainen has an extensive background in clinical research and project management. His career began with roles as a Laboratory Assistant at Åbo Akademi University and a Research Trainee at the University of Turku. He later worked as a Master Student in Klaus Elenius' group at the University of Turku, and as a PhD Student at the University of Helsinki in both the Timo Otonkoski Lab and Eija Jokitalo Lab. His industry experience includes multiple roles at Bayer Pharmaceuticals, where he served as Project Assistant, Clinical Study Manager Trainee, and Clinical Study Manager. He has also worked at Biotie Therapies Corp. as an Assistant.
Achievements
In his role as a Global Trial Manager, Aki Vartiainen leads multifunctional and multinational specialist groups, acting as the primary contact point for country organizations globally. His work focuses on early phases of clinical trials, primarily within oncology, while his research contributions have spanned autoimmune and neurodegenerative diseases. At Bayer Pharmaceuticals, he managed clinical studies and contributed to the company's research efforts during his tenure from 2016 to 2021. His academic and professional experiences have positioned him as a knowledgeable figure in the field of clinical trials and drug development.